Literature DB >> 8543036

Thermal stabilization of a single-chain Fv antibody fragment by introduction of a disulphide bond.

N M Young1, C R MacKenzie, S A Narang, R P Oomen, J E Baenziger.   

Abstract

A disulphide bond was introduced into a single-chain Fv form of the anticarbohydrate antibody, Se155-4 by replacing Ala-L57 of the light chain and Asp-H106 of the heavy chain with cysteines, by site-directed mutagenesis. To maintain the salt-bridge from the latter residue to Arg-H98, Tyr-107 was also altered to Asp. The resulting ds-scFv was shown to retain full antigen-binding activity, by enzyme immunoassay and surface plasmon resonance analysis of binding kinetics. Compared with the parent scFv, the disulphide bonded form was shown to have enhanced thermal stability, by Fourier transform IR spectroscopy. The Tm was raised from 60 degrees C to 69 degrees C. The ds-scFv form thus combines the stable monomeric form of the disulphide form with the expression advantages of the scFv.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543036     DOI: 10.1016/0014-5793(95)01325-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Single-domain antibody fragments with high conformational stability.

Authors:  Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon G J Frenken; Serge Muyldermans; Lode Wyns; Andre Matagne
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

Review 2.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

3.  Engineering anti-vascular endothelial growth factor single chain disulfide-stabilized antibody variable fragments (sc-dsFv) with phage-displayed sc-dsFv libraries.

Authors:  Yi-Jen Huang; Ing-Chien Chen; Chung-Ming Yu; Yu-Ching Lee; Hung-Ju Hsu; Anna Tung Ching Ching; Hung-Ju Chang; An-Suei Yang
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

4.  Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.

Authors:  Jennifer S Michaelson; Stephen J Demarest; Brian Miller; Aldo Amatucci; William B Snyder; Xiufeng Wu; Flora Huang; Samantha Phan; Sharon Gao; Adam Doern; Graham K Farrington; Alexey Lugovskoy; Ingrid Joseph; Veronique Bailly; Xin Wang; Ellen Garber; Jeff Browning; Scott M Glaser
Journal:  MAbs       Date:  2009-03-11       Impact factor: 5.857

Review 5.  Strategies to Address Chimeric Antigen Receptor Tonic Signaling.

Authors:  Adam Ajina; John Maher
Journal:  Mol Cancer Ther       Date:  2018-09       Impact factor: 6.261

6.  Engineered single-domain antibodies with high protease resistance and thermal stability.

Authors:  Greg Hussack; Tomoko Hirama; Wen Ding; Roger Mackenzie; Jamshid Tanha
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

7.  Structural insights and biomedical potential of IgNAR scaffolds from sharks.

Authors:  Stefan Zielonka; Martin Empting; Julius Grzeschik; Doreen Könning; Caroline J Barelle; Harald Kolmar
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 8.  Antibody Fragments as Probe in Biosensor Development.

Authors:  Dirk Saerens; Lieven Huang; Kristien Bonroy; Serge Muyldermans
Journal:  Sensors (Basel)       Date:  2008-08-08       Impact factor: 3.576

9.  Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments.

Authors:  Diana Gil; Adam G Schrum
Journal:  Adv Biosci Biotechnol       Date:  2013-04

10.  ScFvs as Allosteric Inhibitors of VEGFR-2: Novel Tools to Harness VEGF Signaling.

Authors:  Kurt Ballmer-Hofer; Caroline A C Hyde; Thomas Schleier; Dragana Avramovic
Journal:  Int J Mol Sci       Date:  2018-05-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.